CYCN - Cyclerion Therapeutics Inc
Previous close
3.15
0 0%
Share volume: 292
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.15
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-04 | 2022-08-09 | 2022-11-03 | 2023-03-22 | 2023-05-12 | 2023-07-28 | 2023-11-13 | |
| Total revenue | 711.000 K | 306.000 K | 0.000 | 608.000 K | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 711.000 K | 306.000 K | 0.000 | 608.000 K | 0.000 | 0.000 | 0.000 | |
| -56.96% | -100.00% | inf% | -100.00% | nan% | nan% | |||
| Operating expenses | 13.695 M | 13.739 M | 10.607 M | 7.956 M | 7.042 M | 4.243 M | 2.711 M | |
| Selling general and admin | 3.952 M | 3.521 M | 3.525 M | 3.506 M | 3.269 M | 3.357 M | 2.131 M | |
| Research and development | 9.743 M | 10.218 M | 7.082 M | 4.450 M | 3.773 M | 886.000 K | 580.000 K | |
| Total expenses | 13.695 M | 13.739 M | 10.607 M | 7.956 M | 7.042 M | 4.243 M | 2.711 M | |
| 0.32% | -22.80% | -24.99% | -11.49% | -39.75% | -36.11% | |||
| Operating income | -12.984 M | -13.433 M | -10.607 M | -7.348 M | -7.042 M | -4.243 M | -2.711 M | |
| Ebit | -12.984 M | -13.433 M | -10.607 M | -7.348 M | -7.042 M | -4.243 M | -2.711 M | |
| Pretax income | -12.978 M | -13.388 M | -10.496 M | -7.216 M | -6.954 M | -4.181 M | -5.908 M | |
| 3.16% | -21.60% | -31.25% | -3.63% | -39.88% | 41.31% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -12.978 M | -13.388 M | -10.496 M | -7.216 M | -6.954 M | -4.181 M | 7.566 M | |
| -3.16% | 21.60% | 31.25% | 3.63% | 39.88% | 280.96% | |||
| Net income | -12.978 M | -13.388 M | -10.496 M | -7.216 M | -6.954 M | -4.181 M | 7.566 M | |
| -3.16% | 21.60% | 31.25% | 3.63% | 39.88% | 280.96% |